Papers - HATAKEYAMA SHINGO
-
ヌーナン症候群患者に施行した献腎移植の一例
小玉 寛健, 畠山 真吾, 村澤 洋美, 杉山 尚樹, 岡本 亜希子, 山本 勇人, 北原 竜次, 米山 高弘, 橋本 安弘, 齋藤 久夫, 大山 力
日本透析医学会雑誌 54 ( Suppl.1 ) 463 - 463 2021.5
-
Narrative review of urinary glycan biomarkers in prostate cancer.
Hatakeyama S, Yoneyama T, Tobisawa Y, Yamamoto H, Ohyama C.
Transl Androl Urol. 2021.4
-
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.
Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Tadashi Yoshizawa, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama
Urologic oncology 39 ( 4 ) 238.e9 - 238.e17 2021.4
-
Short-term outcomes of risk-adapted upfront docetaxel administration in patients with metastatic hormone-sensitive prostate cancer: a multicenter prospective study in Japan.
Yumina Muto, Shintaro Narita, Shingo Hatakeyama, Shinya Maita, Shuji Chiba, Kyohei Kubo, Yuu Aoyama, Ryuichi Ito, Yoshiko Takahashi, Shuhei Takahashi, Kumiko Nakamura, Naoko Honma, Hiromi Sato, Atsushi Koizumi, Ryoma Igarashi, Katsumi Okane, Toshiya Ishida, Yohei Horikawa, Teruaki Kumazawa, Susumu Akihama, Jiro Shimoda, Takehiro Suzuki, Chikara Ohyama, Tomonori Habuchi
Medical oncology (Northwood, London, England) 38 ( 4 ) 37 - 37 2021.3
-
Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.
Yuka Kubota, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Itsuto Hamano, Sakae Konishi, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
World journal of urology 2021.3
-
Editorial Comment to Regional and facility disparities in androgen deprivation therapy for prostate cancer from a multi-institutional Japan-wide database.
Shingo Hatakeyama, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 2021.3
-
Altered gut microbiome associated with overactive bladder and daily urinary urgency.
Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama
World journal of urology 39 ( 3 ) 847 - 853 2021.3
-
Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).
Iwamura H, Hatakeyama S, Momota M, Kojima Y, Narita T, Okamoto T, Fujita N, Hamano I, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Translational andrology and urology 10 ( 3 ) 1143 - 1151 2021.3
-
ロボット支援腹腔鏡下膀胱全摘除術～現状の課題と今後の方向性～ 当科におけるRARC+U字回腸新膀胱造設術の成績
米山 高弘, 富樫 赳, 堀口 裕貴, 小玉 寛健, 成田 拓麿, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人, 畠山 真吾, 橋本 安弘, 大山 力
日本内視鏡外科学会雑誌 25 ( 7 ) SY16 - 6 2021.3
-
Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study
Tomoko Hamaya, Shingo Hatakeyama, Toshikazu Tanaka, Yuka Kubota, Kyo Togashi, Shogo Hosogoe, Naoki Fujita, Ayumu Kusaka, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
BJU International 128 ( 4 ) 468 - 476 2021.2
-
Editorial Comment from Dr Hatakeyama and Dr Ohyama to Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma.
Shingo Hatakeyama, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 2021.2
-
N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.
Hirotake Kodama, Tohru Yoneyama, Toshikazu Tanaka, Daisuke Noro, Yuki Tobisawa, Hayato Yamamoto, Shinichiro Suto, Shingo Hatakeyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuko Kakizaki, Shigeyuki Nakaji, Chikara Ohyama
Cancer medicine 10 ( 4 ) 1297 - 1313 2021.2
-
献腎移植を施行したヌーナン症候群の一例
小玉 寛健, 畠山 真吾, 村澤 洋美, 杉山 尚樹, 岡本 亜希子, 山本 勇人, 北原 竜次, 米山 高弘, 橋本 安弘, 齋藤 久夫, 大山 力
日本臨床腎移植学会プログラム・抄録集 54回 132 - 132 2021.2
-
血管内皮細胞を標的としたがん特異的療法の開発
畠山 真吾, 米山 徹, 大山 力
細胞 53 ( 2 ) 99 - 103 2021.2
-
Correction to: Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.
Yoneyama T, Hatakeyama S, Sutoh Yoneyama M, Yoshiya T, Uemura T, Ishizu T, Suzuki M, Hachinohe S, Ishiyama S, Nonaka M, Fukuda MN, Ohyama C
BMC cancer 21 ( 1 ) 105 2021.1
-
B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.
Tohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Taku Yoshiya, Tsuyoshi Uemura, Takehiro Ishizu, Minoru Suzuki, Shingo Hachinohe, Shintaro Ishiyama, Motohiro Nonaka, Michiko N Fukuda, Chikara Ohyama
BMC cancer 21 ( 1 ) 72 - 72 2021.1
-
Tumor vasculature-targeted <sup>10</sup>B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.
Yoneyama T, Hatakeyama S, Sutoh Yoneyama M, Yoshiya T, Uemura T, Ishizu T, Suzuki M, Hachinohe S, Ishiyama S, Nonaka M, Fukuda MN, Ohyama C
BMC cancer 21 ( 1 ) 72 2021.1
-
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).
Tomoko Hamaya, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Yuta Kojima, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of clinical oncology 26 ( 1 ) 199 - 206 2021.1
-
Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study.
Koichi Kido, Shingo Hatakeyama, Kazuyuki Numakura, Toshikazu Tanaka, Masaaki Oikawa, Daisuke Noro, Shogo Hosogoe, Shintaro Narita, Takamitsu Inoue, Takahiro Yoneyama, Hiroyuki Ito, Shoji Nishimura, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama
International journal of clinical oncology 26 ( 1 ) 154 - 162 2021.1
-
Response to Re: Geriatric 8 screening of frailty in patients with prostate cancer.
Shingo Hatakeyama, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 27 ( 12 ) 1162 - 1163 2021.1